# SEROQUEL

NDC: 0310-0271
Generic name: quetiapine
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 19971001
Marketing ended: 20270630
FDA application: NDA020639

## Active ingredients

- QUETIAPINE FUMARATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0271"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0271
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0584dda8-bc3c-48fe-1a90-79608f78e8a0